Resultats globals: 7 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Documents de recerca, 2 registres trobats
Articles 5 registres trobats  
1.
16 p, 1.7 MB Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries / Pisana, Alice (Karolinska Institutet (Estocolm, Suècia)) ; Wettermark, Björn (Vilnius University) ; Kurdi, Amanj (Sefako Makgatho Health Sciences University) ; Tubic, Biljana (University of Banja Luka) ; Pontes García, Caridad (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Zara, Corinne (Servei Català de la Salut) ; Van Ganse, Eric (Croix Rousse University Hospital (Lyon, França)) ; Petrova, Guenka (PharmacoEpidemiology Lyon) ; Mardare, Ileana ("Carol Davila" University of Medicine and Pharmacy) ; Fürst, Jurij (Health Insurance Institute) ; Roig-Izquierdo, Marta (Servei Català de la Salut) ; Melien, Oyvind (Oslo University Hospital (Oslo, Noruega)) ; Bonanno, Patricia Vella (University of Malta) ; Banzi, Rita (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ; Marković-Peković, Vanda (University of Banja Luka) ; Mitkova, Zornitsa (PharmacoEpidemiology Lyon) ; Godman, Brian (Ajman University)
Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluation generates uncertainty over their cost-effectiveness and increases expenditure for unknown health gain. [...]
2022 - 10.3389/fphar.2022.873556
Frontiers in Pharmacology, Vol. 13 (june 2022)  
2.
21 p, 621.9 KB The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future / Godman, Brian (Universiti Sains Malaysia) ; Haque, Mainul (Universiti Pertahanan Nasional Malaysia) ; Leong, Trudy (South African National Department of Health) ; Allocati, Eleonora (Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS) ; Kumar, Santosh (Department of Periodontology and Implantology, Karnavati University) ; Islam, Salequl (Department of Microbiology, Jahangirnagar University) ; Charan, Jaykaran (Department of Pharmacology, All India Institute of Medical Sciences) ; Akter, Farhana (Department of Endocrinology, Chittagong Medical College) ; Kurdi, Amanj (Department of Pharmacology, Hawler Medical University) ; Vassalo, Carlos (Facultad de Ciencias Médicas, Universidad Nacional del Litoral) ; Bakar, Muhammed Abu (Department of Endocrinology and Metabolism, Chattogram Maa-O-Shishu Hospital Medical College) ; Rahim, Sagir Abdur (Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders General Hospital) ; Sultana, Nusrat (Department of Endocrinology and Metabolism, Bangabandhu Sheik Mujib Medical University Hospital) ; Deeba, Farzana (Department of Obstetrics and Gynaecology, Bangabandhu Sheik Mujib Medical University) ; Khan, M. A. Halim (Shaheed Suhrawardy Medical College Hospital) ; Alam, A. B. M. Muksudul (Shaheed Suhrawardy Medical College Hospital) ; Jahan, Iffat (Department of Physiology, Eastern Medical College (Bangladesh)) ; Kamal, Zubair Mahmood (National Institute of Mental Health (Bangladesh)) ; Hasin, Humaira (Epsom and St Helier University Hospitals NHS Trust) ; Munzur-E-Murshid (Women's Integrated Sexual Health (WISH) 2 Access Choice Together Innovate Ownership Now (ACTION) Project, Handicap International (Bangladesh)) ; Nahar, Shamsun (Department of Microbiology, Jahangirnagar University) ; Haque, Monami (Human Resource Department Rupayan Center) ; Dutta, Siddhartha (Department of Pharmacology, All India Institute of Medical Sciences) ; Abhayanand, Jha Pallavi (Department of Pharmacology, All India Institute of Medical Sciences) ; Kaur, Rimple Jeet (Department of Pharmacology, All India Institute of Medical Sciences) ; Rwegerera, Godfrey Mutashambara (University of Botswana) ; do Nascimento, Renata Cristina Rezende Macedo (Department of Pharmacy, Federal University of Ouro Preto) ; Dias Godói, Isabella Piassi (Universidade Federal do Sul e Sudeste do Pará) ; Irfan, Mohammed (Faculdade de Odontologia, Universidade Federal de Pelotas) ; Amu, Adefolarin A. (Pharmacy Department, Eswatini Medical Christian University) ; Matowa, Patrick (Pharmacy Department, Eswatini Medical Christian University) ; Acolatse, Joseph (Cape Coast Teaching Hospital) ; Incoom, Robert (Cape Coast Teaching Hospital) ; Sefah, Israel Abebrese (Department of Pharmacy Practise University of Health and Allied Sciences) ; Acharya, Jitendra (Department of Dentistry, SP Medical College) ; Opanga, Sylvia (Department of Pharmaceutics and Pharmacy Practise, University of Nairobi) ; Njeri, Lisper Wangeci (Department of Pharmacy, Kenyatta National Hospital) ; Kimonge, David (Department of Pharmaceutics and Pharmacy Practise, University of Nairobi) ; Kwon, Hye-Young (Mokwon University) ; Bae, SeungJin (Ewha Woman's University) ; Khuan, Karen Koh Pek (Friends'Pharmacy Pekan Sg Besi 42G) ; Abubakar, Abdullahi Rabiu (Department of Pharmacology and Therapeutics, Bayero University) ; Sani, Ibrahim Haruna (Yusuf Maitama Sule University) ; Khan, Tanveer Ahmed (National Institute of Health) ; Hussain, Shahzad (National Institute of Health) ; Saleem, Zikria (Department of Pharmacy Practise, The University of Lahore) ; Malande, Oliver Ombeva (East Africa Centre for Vaccines and Immunisation) ; Piloya-Were, Thereza (Makerere University) ; Gambogi, Rosana (National Resources Fund) ; Hernandez Ortiz, Carla (National Resources Fund) ; Alutuli, Luke (University Teaching Hospital Group, Department of Pharmacy) ; Kalungia, Aubrey Chichonyi (Department of Pharmacy, University of Zambia) ; Hoxha, Iris (Department of Pharmacy, University of Medicine) ; Marković-Peković, Vanda (Department of Social Pharmacy, University of Banja Luka) ; Tubic, Biljana (Department of Medicinal Chemistry, University of Banja Luka) ; Petrova, Guenka (Medical University of Sofia (Sofia, Bulgària)) ; Tachkov, Konstantin (Medical University of Sofia (Sofia, Bulgària)) ; Laius, Ott (State Agency of Medicines) ; Harsanyi, András (Department of Health Policy and Health Economics, Eotvos Lorand University) ; Inotai, András (Center of Health Technology Assessment, Semmelweis University) ; Jakupi, Arianit (UBT Higher Education Institute) ; Henkuzens, Svens ; Garuoliene, Kristina (Vilnius University (Vilnius, Lituània)) ; Gulbinovič, Jolanta (Vilnius University (Vilnius, Lituània)) ; Wladysiuk, Magdalena (HTA Consulting) ; Rutkowski, Jakub (HTA Consulting) ; Mardare, Ileana (Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy Bucharest) ; Fürst, Jurij (Health Insurance Institute) ; McTaggart, Stuart (Public Health Scotland) ; MacBride-Stewart, Sean (Pharmacy Services, Greater Glasgow and Clyde) ; Pontes García, Caridad (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Zara, Corinne (Servei Català de la Salut) ; Tagoe, Eunice Twumwaa (Department of Management Science, University of Strathclyde) ; Banzi, Rita (Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS) ; Wale, Janney (Independent Consumer Advocate) ; Jakovljevic, Mihajlo (Hosei University Tokyo)
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. [...]
2021 - 10.3389/fpubh.2021.671961
Frontiers in Public Health, Vol. 9 (june 2021)  
3.
9 p, 1.5 MB Projections of temperature-attributable mortality in Europe : a time series analysis of 147 contiguous regions in 16 countries / Martínez-Solanas, Èrica ; Quijal-Zamorano, Marcos ; Achebak, Hicham ; Petrova, Desislava ; Robine, Jean-Marie ; Herrmann, François R. ; Rodó, Xavier ; Ballester, Joan
Background. - Europe has emerged as a major climate change hotspot, both in terms of an increase in seasonal averages and climate extremes. Projections of temperature-attributable mortality, however, have not been comprehensively reported for an extensive part of the continent. [...]
2021 - 10.1016/S2542-5196(21)00150-9
The Lancet. Planetary health, Vol. 5 Núm. 7 (2021) , p. 446-454  
4.
13 p, 1.0 MB Adaptive Pathways : Possible Next Steps for Payers in Preparation for Their Potential Implementation / Vella Bonanno, Patricia (Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde) ; Ermisch, Michael (Pharmaceutical Department, National Association of Statutory Health Insurance Funds) ; Godman, Brian (Karolinska Institutet (Estocolm, Suècia). Division of Clinical Pharmacology) ; Martin, Antony P. (Health Economics Centre, University of Liverpool Management School) ; Van Den Bergh, Jesper (Department of Health) ; Bezmelnitsyna, Liudmila (National Research Institution for Public Health) ; Bucsics, Anna (Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA)) ; Arickx, Francis (Department of Pharmaceutical Policy, National Institute for Health and Disability Insurance) ; Bybau, Alexander (Zilveren Kruis Achmea) ; Bochenek, Tomasz (Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College) ; van de Casteele, Marc (Department of Pharmaceutical Policy, National Institute for Health and Disability Insurance) ; Diogène Fadini, Eduard (Hospital Universitari Vall d'Hebron) ; Eriksson, Irene (Karolinska Institutet (Estocolm, Suècia). Department of Medicine Solna) ; Fürst, Jurij (Medicinal Products Department, Health Insurance Institute of Slovenia) ; Gad, Mohamed (Global Health and Development Group, Imperial College) ; Greičiūtė-Kuprijanov, Ieva (Department of Pharmacy, Ministry of Health of the Republic of Lithuania) ; van der Graaff, Martin (National Health Care Institute (ZIN)) ; Gulbinovič, Jolanta (State Medicines Control Agency) ; Jones, Jan (Scottish Medicines Consortium) ; Joppi, Roberta (Clinical Research and Drug Assessment Unit) ; Kalaba, Marija (Pediatric Cardiology, Primary Healthcare Centre "Zemun") ; Laius, Ott (Department of Post-authorisation Safety, State Agency of Medicines) ; Langner, Irene (Wissenschaftliches Institut der AOK) ; Mardare, Ileana (Faculty of Medicine, Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy Bucharest) ; Markovic-Pekovic, Vanda (Department of Social Pharmacy, Medical Faculty, University of Banja Luka) ; Magnusson, Einar (Department of Health Services, Ministry of Health) ; Melien, Oyvind (Norwegian Directorate for Health) ; Meshkov, Dmitry O. (Department of Health) ; Petrova, Guenka I. (Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia) ; Selke, Gisbert (Wissenschaftliches Institut der AOK) ; Sermet, Catherine (Institut de Recherche et Documentation en Economie de la Santé (IRDES)) ; Simoens, Steven (KU Leuven Department of Pharmaceutical and Pharmacological Sciences) ; Schuurman, Ad (National Health Care Institute (ZIN)) ; Ramos, Ricardo (Health Technology Assessment, Pricing and Reimbursement Department, Central Administration of the Health System, National Authority of Medicines and Health Products (I.P., INFARMED)) ; Rodrigues, Jorge (Health Technology Assessment, Pricing and Reimbursement Department, Central Administration of the Health System, National Authority of Medicines and Health Products (I.P., INFARMED)) ; Zara, Corinne (Servei Català de la Salut) ; Zebedin-Brandl, Eva (Main Association of Austrian Social Insurance Institutions. Department of Pharmaceutical Affairs) ; Haycox, Alan (Health Economics Centre, University of Liverpool Management School) ; Universitat Autònoma de Barcelona
Medicines receiving a conditional marketing authorization through Medicines Adaptive Pathways to Patients (MAPPs) will be a challenge for payers. The "introduction" of MAPPs is already seen by the European Medicines Agency (EMA) as a fait accompli, with payers not consulted or involved. [...]
2017 - 10.3389/fphar.2017.00497
Frontiers in Pharmacology, Vol. 8 (august 2017)  
5.
22 p, 534.9 KB The Reception of Latin Grammar Knowledge in the Early Middle Ages: Bede and Donatus / Petrova, Maya (Russian Academy of Sciences. Institute of World History (Rússia))
The article treats the grammatical tradition of Late Antiquity and its reception in the early Middle Ages. Bede's rhetorical and grammatical works are analysed in the context of medieval school practice; the question of the extent to which Bede's texts depend on Aelius Donatus' Ars grammatica is considered; the parallels and differences between their texts are discussed.
O artigo trata da tradição gramatical Tardo Antiga e sua recepção na Primeira Idade Média. Os trabalhos retóricos e gramaticais de Beda são anaçisados no contexto de práticas escolares medievais; a questão de quanto os textos de Beda dependem do Ars Grammatica de Aélio Donato é considerada; os paralelos e diferenças entre os textos são discutidos.

2014
Mirabilia, Núm. 18 (January-June 2014) , p. 45-66  

Documents de recerca 2 registres trobats  
1.
33 p, 619.9 KB Changes in the demand for private medical insurance following a shift in tax incentives / Rodrí­guez Martí­nez, Marisol, 1951- (Universitat de Barcelona. Departament de Política Econòmica i Estructura Econòmica Mundial) ; Stoyanova, Alexandrina Petrova (Universitat Pompeu Fabra. Departament d'Economia i Empresa) ; Xarxa de Referència en Economia Aplicada (XREAP)
The 1998 Spanish reform of the Personal Income Tax eliminated the 15% deduction for private medical expenditures including payments on private health insurance (PHI) policies. To avoid an undesirable increase in the demand for publicly funded health care, tax incentives to buy PHI were not completely removed but basically shifted from individual to group employer-paid policies. [...]
Xarxa de Referència en Economia Aplicada (XREAP) 2006 (CREAP ; 2006-12)  
2.
29 p, 107.3 KB The causal relationship between Individual's choice behavior and self-reported satisfaction : the case of residential mobility in the EU / Díaz Serrano, Lluís (Universitat Rovira i Virgili) ; Stoyanova, Alexandrina Petrova (Universitat de Barcelona) ; Xarxa de Referència en Economia Aplicada (XREAP)
One of the most persistent and lasting debates in economic research refers to whether the answers to subjective questions can be used to explain individuals' economic behavior. Using panel data for twelve EU countries, in the present study we analyze the causal relationship between self-reported housing satisfaction and residential mobility. [...]
Xarxa de Referència en Economia Aplicada (XREAP) 2008 (XREAP ; 2008-02)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.